✦ LIBER ✦
Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody
✍ Scribed by Paul E. Monahan; Louis M. Aledort
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 84 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Achieving adequate hemostasis in patients with hemophilia and high‐titer inhibitor antibodies remains a challenge despite the development of plasma‐derived and recombinant therapies to bypass the inhibitory effect. A group of hemophilia treaters met to examine the factors that influence physician choices among the very costly and cumbersome available therapies. Specific knowledge deficits in need of prospective research were identified with respect to the rational treatment of inhibitor patients. Am. J. Hematol. 77:346–350, 2004. © 2004 Wiley‐Liss, Inc.